Equities

Kuangli Bio Tech Holdings Co Ltd

6431:TAI

Kuangli Bio Tech Holdings Co Ltd

Actions
Consumer DiscretionaryPersonal Goods
  • Price (TWD)16.95
  • Today's Change0.35 / 2.11%
  • Shares traded108.42k
  • 1 Year change+5.28%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments91163183
Total Receivables, Net136163231
Total Inventory456397
Prepaid expenses331111
Other current assets, total------
Total current assets306400523
Property, plant & equipment, net381364382
Goodwill, net129140138
Intangibles, net169190204
Long term investments----0
Note receivable - long term11----
Other long term assets135.66--
Total assets1,0431,1161,249
LIABILITIES
Accounts payable223095
Accrued expenses111716
Notes payable/short-term debt147148148
Current portion long-term debt/capital leases743124
Other current liabilities, total284745
Total current liabilities283273328
Total long term debt200170176
Total debt422350348
Deferred income tax------
Minority interest--0260
Other liabilities, total2.4902.18
Total liabilities485443767
SHAREHOLDERS EQUITY
Common stock572572512
Additional paid-in capital187187252
Retained earnings (accumulated deficit)(272)(168)(243)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(43)(32)(38)
Total equity558673482
Total liabilities & shareholders' equity1,0431,1161,249
Total common shares outstanding575751
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.